Apollo Medical (NASDAQ: AMEH) is one of 29 publicly-traded companies in the “Management consulting services” industry, but how does it weigh in compared to its rivals? We will compare Apollo Medical to related companies based on the strength of its profitability, institutional ownership, analyst recommendations, dividends, valuation, risk and earnings.
This is a summary of recent recommendations for Apollo Medical and its rivals, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Apollo Medical Competitors||160||489||665||40||2.43|
Apollo Medical currently has a consensus target price of $25.00, indicating a potential upside of 30.89%. As a group, “Management consulting services” companies have a potential upside of 16.15%. Given Apollo Medical’s stronger consensus rating and higher probable upside, analysts plainly believe Apollo Medical is more favorable than its rivals.
This table compares Apollo Medical and its rivals’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Apollo Medical Competitors||-20.27%||-9.55%||-10.93%|
Insider and Institutional Ownership
6.7% of Apollo Medical shares are held by institutional investors. Comparatively, 62.2% of shares of all “Management consulting services” companies are held by institutional investors. 20.5% of Apollo Medical shares are held by insiders. Comparatively, 13.7% of shares of all “Management consulting services” companies are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Valuation & Earnings
This table compares Apollo Medical and its rivals revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Apollo Medical||$519.91 million||$10.84 million||65.86|
|Apollo Medical Competitors||$1.71 billion||$120.52 million||26.75|
Apollo Medical’s rivals have higher revenue and earnings than Apollo Medical. Apollo Medical is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.
Risk and Volatility
Apollo Medical has a beta of -1.17, meaning that its share price is 217% less volatile than the S&P 500. Comparatively, Apollo Medical’s rivals have a beta of 1.08, meaning that their average share price is 8% more volatile than the S&P 500.
Apollo Medical beats its rivals on 8 of the 13 factors compared.
Apollo Medical Company Profile
Apollo Medical Holdings, Inc., an integrated health care delivery and management company, provides medical care services. The company offers care coordination services to principal constituents of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. Its physician network consists of primary care physicians, specialist physicians, and hospitalists. The company serves the patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organizations; and non-insured patients in California. Apollo Medical Holdings, Inc. is based in Alhambra, California.
Receive News & Ratings for Apollo Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apollo Medical and related companies with MarketBeat.com's FREE daily email newsletter.